Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.
Value-based care is a health care model that focuses on the patient experience, quality of care, and provider performance, with a goal of managing a patient’s overall health while considering their individual health goals.1 The model offers patients an easier time when navigating the health care industry and more options in how they receive care.
At the Spring 2024 Total Pharmacy Solutions Summit, held virtually on April 13, Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy, as well as how to improve operations and clinical services.
“What is value-based care?” Canally asked during the session. “[It] has many different definitions. But an easy one is, it’s an evolving health care model moving pharmacy from transaction-based care to clinical-based services designed to improve patient satisfaction and outcomes. In other words, you’re prioritizing quality over quantity. It’s far more beneficial to the patient and, hopefully, cost-effective to the pharmacist.”
READ MORE: Data, Collaboration Can Help Unlock the Full Potential of Value-Based Care
“Pharmacists who embrace value-based care will be well positioned to meet the needs of their patients and the health care system in the future,” Canally said. “Value-based care models can lead to a number of positive outcomes, including…not only improving medication adherence but reduced hospital readmissions [and] lower health care costs because [patients] are not going back for…readmissions; they’re not going to the [emergency department] because through your counseling, you’re preventing them from needing to do that.”
Visit drugtopics.com/Spring24TPSS to watch all of the Total Pharmacy Solutions Summit sessions on demand.
Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.